Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults
Conclusions:
This meta-analysis revealed that the addition of moxifloxacin to the recommended regimen significantly improved the rate of treatment success in the treatment of MDR-TB, with no additional adverse moxifloxacin events.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Avelox | Coccidioidomycosis (Valley Fever) | Databases & Libraries | Dermatology | Gastroenterology | Internal Medicine | Levaquin | Moxifloxacin | Multidrug Resistance | Skin | Statistics | Study | Tuberculosis